These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5773672)

  • 1. Biphasic inhibition of urokinase-induced fibrinolysis by epsilon-aminocaproic acid; distinction from tissue plasminogen activator.
    Thorsen S; Astrup T
    Proc Soc Exp Biol Med; 1969 Mar; 130(3):811-3. PubMed ID: 5773672
    [No Abstract]   [Full Text] [Related]  

  • 2. Tranexamic acid and fibrinolytic activity of the vessel wall.
    Astedt B; Liedholm P
    Experientia; 1974 Jul; 30(7):776-7. PubMed ID: 4847668
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of tranexamic acid, cis-AMCHA, and 6-aminohexanoic acid on the activation rate of plasminogen by urokinase in the presence of clot.
    Takada A; Ohashi H; Matsuda H; Takada Y
    Thromb Res; 1979; 14(6):915-23. PubMed ID: 473126
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthetic inhibitors of fibrinolysis: in vitro and in vivo mode of action.
    Okamoto S; Oshiba S; Mihara H; Okamoto U
    Ann N Y Acad Sci; 1968 Jun; 146(2):414-29. PubMed ID: 5254270
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasminogen-plasmin system. 3. Kinetics of plasminogen activation and inhibition of plasminogen-plasmin system by some synthetic inhibitors.
    Iwamoto M; Abiko Y; Shimizu M
    J Biochem; 1968 Dec; 64(6):759-67. PubMed ID: 4238017
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the mechanism of action of synthetic antifibrinolytics. A comparison with the action of derivatives of benzamidine on the fibrinolytic process.
    Landmann H
    Thromb Diath Haemorrh; 1973 May; 29(2):253-75. PubMed ID: 4271586
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative assessment of fibrinolysis on isolated glomeruli.
    Sraer JD; Boelaert J; Mimoune O; Morel-Maroger L; Hornych H
    Kidney Int; 1973 Nov; 4(5):350-2. PubMed ID: 4762582
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of antifibrinolytic substances on allergic reactions. Experiments with epsilon-aminocaproic acid and amino-methyl-cyclohexane-carbonic acid.
    Raab W
    Experientia; 1968 Mar; 24(3):250. PubMed ID: 5661420
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antiplasmins].
    Enache F; Cecil P
    Med Interna (Bucur); 1970 Jun; 22(6):667-76. PubMed ID: 4917257
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of tissue penetrability and therapeutic dose of epsilon-aminocaproic acid, AMCHA and trasylol with the help of direct homogenate- plasma-thromboelastography examplified on the fibrinolytically active myometrium].
    Schmidt-Matthiesen H; Schreinert B
    Klin Wochenschr; 1968 Jul; 46(13):730-1. PubMed ID: 5306518
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative activities of amino acid and polypeptide inhibitors on natural and synthetic substrates.
    Skoza L; Tse AO; Semar M; Johnson AJ
    Ann N Y Acad Sci; 1968 Jun; 146(2):659-72. PubMed ID: 4239440
    [No Abstract]   [Full Text] [Related]  

  • 12. Some properties of the tissue plasminogen activator from the pig heart.
    Hijikata A; Fujimoto K; Kitaguchi H; Okamoto S
    Thromb Res; 1974 Jun; 4(6):731-40. PubMed ID: 4844057
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA.
    Andersson L; Nilsoon IM; Colleen S; Granstrand B; Melander B
    Ann N Y Acad Sci; 1968 Jun; 146(2):642-58. PubMed ID: 5254275
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and activity of dipeptides containing epsilon-aminocaproic acid.
    Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Worowski K
    Acta Pol Pharm; 1994; 51(6):499-504. PubMed ID: 7762400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the action mechanism of some fibrinolysis inhibitors.
    Donner L; Housková J
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):439-46. PubMed ID: 4952977
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative clinical-pharmacological studies on synthetic antifibrinolytic agents].
    Markwardt F; Klöcking HP; Landmann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):78-83. PubMed ID: 4189376
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the mechanism of action of inhibitors of the fibrinolysin system.
    Ambrus CM; Ambrus JL; Lassman HB; Mink IB
    Ann N Y Acad Sci; 1968 Jun; 146(2):430-47. PubMed ID: 4239437
    [No Abstract]   [Full Text] [Related]  

  • 18. The changes of the tissue plasminogen activator levels in the endometrium during antifibrinolytic therapy.
    Koutský J; Rybák M; Jirásek JE; Hladovec J; Mansfeld V
    Gynaecologia; 1969; 167(4):265-70. PubMed ID: 5767879
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antifibrinolytic therapy of gynecologic hemorrhages (literature survey)].
    Skipetrov VP
    Akush Ginekol (Mosk); 1974 Oct; (10):1-6. PubMed ID: 4280255
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of omega-aminoacids and clot formation on the activation by urokinase of various plasminogen preparations.
    Takada A; Takada Y
    Thromb Res; 1980 Apr 1-15; 18(1-2):167-76. PubMed ID: 6773180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.